Use of Novel Coagulation Proteins: Recombinant Human Activated Protein C (rhAPC) in Severe Sepsis
Program Code: 206-S
Sunday, October 24, 2004
8:30 AM to 10:00 AM (ET)

SPEAKERS
Arthur Wheeler, MD, Vanderbilt University Medical Center
Peter Morris, MD, Wake Forest University School of Medicine

DESCRIPTION
This session will orient the noncritical-care physician and health-care worker to the patients with severe sepsis, outline the mechanism of action and present the clinical benefits of this novel coagulation protein therapy, rhAPC.

AUDIENCE
Physicians, Technologists, Nurses, Managers/Supervisors

PROGRAM LEVEL
Advanced